Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Journal of Hand Surgery (European Volume)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by JONES, N. F.
Right arrow Articles by URIST, M. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by JONES, N. F.
Right arrow Articles by URIST, M. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Articles

Bone Morphogenetic Protein as an Adjuvant in the Treatment of Kienbock’s Disease by Vascular Pedicle Implantation

N. F. JONES, E. E. BROWN, E. VÖGELIN and M. R. URIST

From the UCLA Hand Center, Department of Orthopaedic Surgery and Division of Plastic and Reconstructive Surgery, University of California Los Angeles, CA, USA

Correspondence: Neil F. Jones, MD, UCLA Hand Center, 10945 LeConte Avenue #3355, Los Angeles, CA 90095, USA. Tel.: +310 794 7784; fax: +310 206 0063. E-mail: njones{at}mednet.ucla.edu.

This case report documents the first use of bone morphogenetic protein (BMP) as an adjuvant to revascularisation with a first dorsal metacarpal arterio-venous pedicle in the treatment of a patient with Stage III Kienbock’s disease. The patient had complete relief of her symptoms of wrist pain by 8 months postoperatively, when X-rays showed no further evidence of lunate collapse and an MRI scan demonstrated islands of revascularisation. It is impossible to prove unequivocably that BMP contributed to the result seen in this one patient, but this adjuvant concept is based on experimental evidence demonstrating that optimal bioengineering of vascularised bone is dependent on four factors – a structural matrix, progenitor cells, BMP and a vascular supply, and BMP may play a future role in promoting new bone formation in Kienbock’s disease.

Key Words: bone morphogenetic protein • Kienbock’s disease

Journal of Hand Surgery (European Volume), Vol. 33, No. 3, 317-321 (2008)
DOI: 10.1177/1753193408090394
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?